<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NewsInferno &#187; Bisphosphonates</title>
	<atom:link href="http://www.newsinferno.com/category/pharmaceuticals/bisphosphonates/feed" rel="self" type="application/rss+xml" />
	<link>http://www.newsinferno.com</link>
	<description>The News That Matters</description>
	<lastBuildDate>Tue, 22 May 2012 14:20:57 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Bisphosphonate Study Confirms Atypical Thigh Fracture Risk</title>
		<link>http://www.newsinferno.com/pharmaceuticals/bisphosphonate-study-confirms-atypical-thigh-fracture-risk/37926</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/bisphosphonate-study-confirms-atypical-thigh-fracture-risk/37926#comments</comments>
		<pubDate>Tue, 22 May 2012 14:20:57 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Fosamax Bisphosphonate Side Effects]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=37926</guid>
		<description><![CDATA[New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/bisphosphonate-study-confirms-atypical-thigh-fracture-risk/37926">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/bisphosphonate-study-confirms-atypical-thigh-fracture-risk/37926/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conflicting Studies on Oral Bisphosphonates, Esophageal Cancer Yield Confusion</title>
		<link>http://www.newsinferno.com/pharmaceuticals/conflicting-studies-on-oral-bisphosphonates-esophageal-cancer-yield-confusion/37319</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/conflicting-studies-on-oral-bisphosphonates-esophageal-cancer-yield-confusion/37319#comments</comments>
		<pubDate>Thu, 03 May 2012 13:31:57 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Fosamax Bisphosphonate Side Effects]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=37319</guid>
		<description><![CDATA[Federal drug regulators in the U.S. are currently reviewing two conflicting studies examining a possible association between oral bisphosphonates, like Fosamax, and esophageal cancer. According to a report in The Wall Street Journal, it’s difficult to discern which of the &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/conflicting-studies-on-oral-bisphosphonates-esophageal-cancer-yield-confusion/37319">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/conflicting-studies-on-oral-bisphosphonates-esophageal-cancer-yield-confusion/37319/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Long-Term Fosamax Use May Raise Esophageal Cancer Risk</title>
		<link>http://www.newsinferno.com/pharmaceuticals/long-term-fosamax-use-may-raise-esophageal-cancer-risk/36530</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/long-term-fosamax-use-may-raise-esophageal-cancer-risk/36530#comments</comments>
		<pubDate>Tue, 03 Apr 2012 14:39:11 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=36530</guid>
		<description><![CDATA[Oral bisphosphonates, including Fosamax, may increase risks for esophageal cancer if they are used for longer than 5 years. In September 2010, a study published in the British Medical Journal found that people who had taken the oral bisphosphonates over &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/long-term-fosamax-use-may-raise-esophageal-cancer-risk/36530">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/long-term-fosamax-use-may-raise-esophageal-cancer-risk/36530/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Eye Disorders Another Possible Bisphosphonate Side Effect</title>
		<link>http://www.newsinferno.com/pharmaceuticals/eye-disorders-another-possible-bisphosphonate-side-effect/36518</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/eye-disorders-another-possible-bisphosphonate-side-effect/36518#comments</comments>
		<pubDate>Mon, 02 Apr 2012 19:12:16 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=36518</guid>
		<description><![CDATA[Fosamax and other bisphosphonates used by millions of women to prevent osteoporosis may make it more likely that they will suffer anterior uveitis and scleritis, serious inflammatory eye disorders. Uveitis is inflammation of the middle layer of the eye, which &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/eye-disorders-another-possible-bisphosphonate-side-effect/36518">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/eye-disorders-another-possible-bisphosphonate-side-effect/36518/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bisphosphonate Litigation Moving Forward, As FDA Approves Generic Boniva</title>
		<link>http://www.newsinferno.com/pharmaceuticals/bisphosphonate-litigation-moving-forward-as-fda-approves-generic-boniva/36309</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/bisphosphonate-litigation-moving-forward-as-fda-approves-generic-boniva/36309#comments</comments>
		<pubDate>Wed, 21 Mar 2012 18:32:24 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=36309</guid>
		<description><![CDATA[The U.S. Food and Drug Administration (FDA) this week approved the first generic versions of the bisphosphonate, ibandronate (Boniva). The announcement comes just as litigation involving bisphosphonate side effect lawsuits is heating up in both state and federal courts. Ibandronate &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/bisphosphonate-litigation-moving-forward-as-fda-approves-generic-boniva/36309">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/bisphosphonate-litigation-moving-forward-as-fda-approves-generic-boniva/36309/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>National Law Firm Files 36 Fosamax Femur Fracture Lawsuits</title>
		<link>http://www.newsinferno.com/pharmaceuticals/national-law-firm-files-36-fosamax-femur-fracture-lawsuits/36199</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/national-law-firm-files-36-fosamax-femur-fracture-lawsuits/36199#comments</comments>
		<pubDate>Thu, 15 Mar 2012 14:46:10 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=36199</guid>
		<description><![CDATA[Earlier this month, the national law firm of Parker Waichman LLP filed 36 Fosamax femur fracture lawsuits in the Fosamax side effects mass tort currently underway in New Jersey Superior Court. All of the lawsuits allege that the long-term use &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/national-law-firm-files-36-fosamax-femur-fracture-lawsuits/36199">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/national-law-firm-files-36-fosamax-femur-fracture-lawsuits/36199/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stopping Bisphosphonates May Reduce Femur Fracture Risk</title>
		<link>http://www.newsinferno.com/pharmaceuticals/stopping-bisphosphonates-may-reduce-femur-fracture-risk/35593</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/stopping-bisphosphonates-may-reduce-femur-fracture-risk/35593#comments</comments>
		<pubDate>Wed, 08 Feb 2012 19:28:48 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=35593</guid>
		<description><![CDATA[Stopping bisphosphonates, a class of osteoporosis drugs that builds bone, could reduce risks for femur fracture by half, according to growing research. The rare, but serious, thigh bone fracture, known as atypical femur fracture, has been linked to oral bisphosphonates &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/stopping-bisphosphonates-may-reduce-femur-fracture-risk/35593">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/stopping-bisphosphonates-may-reduce-femur-fracture-risk/35593/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Judge Refuses To Overturn Zometa Dead Jaw Verdict</title>
		<link>http://www.newsinferno.com/pharmaceuticals/judge-refuses-to-overturn-zometa-dead-jaw-verdict/34419</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/judge-refuses-to-overturn-zometa-dead-jaw-verdict/34419#comments</comments>
		<pubDate>Wed, 30 Nov 2011 20:23:02 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=34419</guid>
		<description><![CDATA[A federal judge has refused to overturn a verdict Zometa dead jaw lawsuit. Previously, a jury agreed that the drug maker neglected to appropriately warn about the risks connected to its bone-strengthening medications, Zometa and Aredia, such as severe jaw &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/judge-refuses-to-overturn-zometa-dead-jaw-verdict/34419">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/judge-refuses-to-overturn-zometa-dead-jaw-verdict/34419/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fosamax, Other Osteoporosis Drugs Need Stronger Warnings, FDA Advisors Say</title>
		<link>http://www.newsinferno.com/pharmaceuticals/fosamax-other-osteoporosis-drugs-need-stronger-warnings-fda-advisors-say/33206</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/fosamax-other-osteoporosis-drugs-need-stronger-warnings-fda-advisors-say/33206#comments</comments>
		<pubDate>Mon, 12 Sep 2011 18:38:08 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=33206</guid>
		<description><![CDATA[A panel of Food &#038; Drug Administration (FDA) advisors said on Friday that Fosamax and similar bone drugs need stronger warnings regarding duration of use because of their possible long-term risks. But the panel could not agree if use of &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/fosamax-other-osteoporosis-drugs-need-stronger-warnings-fda-advisors-say/33206">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/fosamax-other-osteoporosis-drugs-need-stronger-warnings-fda-advisors-say/33206/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Five Years on Fosamax, Other Bone Drugs May be Adequate, FDA Says</title>
		<link>http://www.newsinferno.com/pharmaceuticals/five-years-on-fosamax-other-bone-drugs-may-be-adequate-fda-says/33159</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/five-years-on-fosamax-other-bone-drugs-may-be-adequate-fda-says/33159#comments</comments>
		<pubDate>Thu, 08 Sep 2011 18:06:15 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=33159</guid>
		<description><![CDATA[Fosamax, Actonel, Boniva and other oral bisphosphonates don&#8217;t have to be taken beyond five years in order to prevent broken bones from osteoporosis, a new U.S. Food &#038; Drug Administration (FDA) report says. The report was released yesterday, two days &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/five-years-on-fosamax-other-bone-drugs-may-be-adequate-fda-says/33159">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/five-years-on-fosamax-other-bone-drugs-may-be-adequate-fda-says/33159/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>FDA Panel to Discuss Long-Term Use of Fosamax, other Bone Drugs</title>
		<link>http://www.newsinferno.com/pharmaceuticals/bisphosphonates/fda-panel-to-discuss-long-term-use-of-fosamax-other-bone-drugs/33117</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/bisphosphonates/fda-panel-to-discuss-long-term-use-of-fosamax-other-bone-drugs/33117#comments</comments>
		<pubDate>Tue, 06 Sep 2011 17:28:59 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=33117</guid>
		<description><![CDATA[A U.S. Food &#038; Drug Administration (FDA) advisory panel is set to examine the safety of oral bisphosphonates later this week. The FDA advisory panel meeting, set to start of Friday, is being convened because of concerns that long-term use &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/bisphosphonates/fda-panel-to-discuss-long-term-use-of-fosamax-other-bone-drugs/33117">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/bisphosphonates/fda-panel-to-discuss-long-term-use-of-fosamax-other-bone-drugs/33117/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Reclast Raises Kidney Risks for Some Patients, FDA Warns</title>
		<link>http://www.newsinferno.com/pharmaceuticals/reclast-raises-kidney-risks-for-some-patients-fda-warns/33094</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/reclast-raises-kidney-risks-for-some-patients-fda-warns/33094#comments</comments>
		<pubDate>Fri, 02 Sep 2011 17:53:18 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=33094</guid>
		<description><![CDATA[The label for osteoporosis medication, Reclast (zoledronic acid), is being updated over its links to serious, adverse kidney reactions, the U.S. Food and Drug Administration (FDA) just announced. Reclast, a drug in the class bisphosphonates, has been linked to increased &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/reclast-raises-kidney-risks-for-some-patients-fda-warns/33094">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/reclast-raises-kidney-risks-for-some-patients-fda-warns/33094/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral Bisphosphonates under Review for Possible Link to Esophageal Cancer</title>
		<link>http://www.newsinferno.com/pharmaceuticals/bisphosphonates/oral-bisphosphonates-under-review-for-possible-link-to-esophageal-cancer/32342</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/bisphosphonates/oral-bisphosphonates-under-review-for-possible-link-to-esophageal-cancer/32342#comments</comments>
		<pubDate>Thu, 21 Jul 2011 19:19:43 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=32342</guid>
		<description><![CDATA[Evidence tying the use of oral bisphosphonates, a class of drugs that includes Fosamax, Actonel, Boniva, Atelvia, Didronel, and Skelid, to esophageal cancer is inconclusive so far, according to a Drug Safety Communication issued today by the U.S. Food &#038; &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/bisphosphonates/oral-bisphosphonates-under-review-for-possible-link-to-esophageal-cancer/32342">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/bisphosphonates/oral-bisphosphonates-under-review-for-possible-link-to-esophageal-cancer/32342/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>People Taking Bisphosphonates Need More Vitamin D</title>
		<link>http://www.newsinferno.com/pharmaceuticals/people-taking-bisphosphonates-need-more-vitamin-d/31616</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/people-taking-bisphosphonates-need-more-vitamin-d/31616#comments</comments>
		<pubDate>Thu, 09 Jun 2011 19:19:13 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=31616</guid>
		<description><![CDATA[Bisphosphonates, such as Fosamax, Boniva, and Actonel, have long been linked to potential risks for increased thigh fractures. Now, said the LA Times, it seems that Vitamin D, which collaborates with calcium to strengthen bones, might help increase the power &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/people-taking-bisphosphonates-need-more-vitamin-d/31616">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/people-taking-bisphosphonates-need-more-vitamin-d/31616/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fracture Risk Prompts Experts to Recommend Bisphosphonate Changes</title>
		<link>http://www.newsinferno.com/pharmaceuticals/fracture-risk-prompts-experts-to-recommend-bisphosphonate-changes/31117</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/fracture-risk-prompts-experts-to-recommend-bisphosphonate-changes/31117#comments</comments>
		<pubDate>Fri, 13 May 2011 17:16:13 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=31117</guid>
		<description><![CDATA[Experts are recommending that doctors change the way they prescribe bisphosphonates like Fosamax, in light of recent research indicating the osteoporosis drugs may be associated with serious thigh fractures. The changes impact not only who may be treated with bisphosphonates &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/fracture-risk-prompts-experts-to-recommend-bisphosphonate-changes/31117">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/fracture-risk-prompts-experts-to-recommend-bisphosphonate-changes/31117/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Swedish Bone Drug Study Confirms Rare Thigh Fracture Risk</title>
		<link>http://www.newsinferno.com/pharmaceuticals/swedish-bone-drug-study-confirms-rare-thigh-fracture-risk/30898</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/swedish-bone-drug-study-confirms-rare-thigh-fracture-risk/30898#comments</comments>
		<pubDate>Thu, 05 May 2011 16:10:53 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=30898</guid>
		<description><![CDATA[Bisphosphonates, a class of drugs used to treat osteoporosis that includes Aclasta, Actonel, Aredia, Bondronat, Boniva, Didronel, Fosamax, Fosavance, Reclast, Skelid, and Zometa, do increase the risk of certain rare thigh fractures, according to a new study out of Sweden. &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/swedish-bone-drug-study-confirms-rare-thigh-fracture-risk/30898">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/swedish-bone-drug-study-confirms-rare-thigh-fracture-risk/30898/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nexium, Fosamax Lawsuits Claim Drugs Caused Fractures</title>
		<link>http://www.newsinferno.com/pharmaceuticals/nexium-fosamax-lawsuits-claim-drugs-caused-fractures/30760</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/nexium-fosamax-lawsuits-claim-drugs-caused-fractures/30760#comments</comments>
		<pubDate>Thu, 28 Apr 2011 17:13:49 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Proton Pump Inhibitors]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=30760</guid>
		<description><![CDATA[Weâ€™ve long been writing about links with proton pump inhibitors (PPIs), such as Nexium, and bisphosphonates, such as Fosamax, to increased risks of bone fractures. PPIs reduce stomach acid and are typically taken for heartburn and acid reflux. Bisphosphonates are &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/nexium-fosamax-lawsuits-claim-drugs-caused-fractures/30760">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/nexium-fosamax-lawsuits-claim-drugs-caused-fractures/30760/feed</wfw:commentRss>
		<slash:comments>9</slash:comments>
		</item>
		<item>
		<title>Osteoporosis Drugs Linked to Thigh Fractures, Yet Again</title>
		<link>http://www.newsinferno.com/pharmaceuticals/osteoporosis-drugs-linked-to-thigh-fractures-yet-again/28818</link>
		<comments>http://www.newsinferno.com/pharmaceuticals/osteoporosis-drugs-linked-to-thigh-fractures-yet-again/28818#comments</comments>
		<pubDate>Wed, 23 Feb 2011 19:06:42 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Defective Drug Lawsuit]]></category>
		<category><![CDATA[Defective Drug Lawyer]]></category>
		<category><![CDATA[Defective Drugs]]></category>
		<category><![CDATA[personal injury]]></category>
		<category><![CDATA[personal injury lawyer]]></category>
		<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=28818</guid>
		<description><![CDATA[Bone loss drugs in the class of bisphosphonates have, again, been linked to bone fractures of the femur (thigh bone). Web MD said that a recent, large review of over 200,000 post-menopausal women found that those taking bisphosphonatesâ€”drugs sold under &#8230; <a href="http://www.newsinferno.com/pharmaceuticals/osteoporosis-drugs-linked-to-thigh-fractures-yet-again/28818">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/pharmaceuticals/osteoporosis-drugs-linked-to-thigh-fractures-yet-again/28818/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proton Pump Inhibitors May Reduce Benefits of Fosamax, other Bone Drugs</title>
		<link>http://www.newsinferno.com/legal-news/proton-pump-inhibitors-may-reduce-benefits-of-fosamax-other-bone-drugs/28498</link>
		<comments>http://www.newsinferno.com/legal-news/proton-pump-inhibitors-may-reduce-benefits-of-fosamax-other-bone-drugs/28498#comments</comments>
		<pubDate>Wed, 16 Feb 2011 14:27:06 +0000</pubDate>
		<dc:creator>Laurie</dc:creator>
				<category><![CDATA[Bisphosphonates]]></category>
		<category><![CDATA[Legal News]]></category>
		<category><![CDATA[Defective Drug Lawsuit]]></category>
		<category><![CDATA[Defective Drug Lawyer]]></category>
		<category><![CDATA[Defective Drugs]]></category>
		<category><![CDATA[Proton Pump Inhibitor Side Effects]]></category>

		<guid isPermaLink="false">http://www.newsinferno.com/?p=28498</guid>
		<description><![CDATA[Popular heartburn drugs called proton pump inhibitors (PPIs) could interfere with the effectiveness of Fosamax and other osteoporosis drugs known as bisphosphonates. According to an observational study published in the &#8220;Archives of Internal Medicine,&#8221; PPIs and bisphosphonates are often used &#8230; <a href="http://www.newsinferno.com/legal-news/proton-pump-inhibitors-may-reduce-benefits-of-fosamax-other-bone-drugs/28498">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.newsinferno.com/legal-news/proton-pump-inhibitors-may-reduce-benefits-of-fosamax-other-bone-drugs/28498/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

